DARS expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.302200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.972300E-02
Normal-vs-Stage2
5.014000E-01
Normal-vs-Stage3
4.190100E-02
Normal-vs-Stage4
3.565600E-01
Stage1-vs-Stage2
2.713400E-01
Stage1-vs-Stage3
4.688800E-01
Stage1-vs-Stage4
1.708210E-01
Stage2-vs-Stage3
1.523770E-01
Stage2-vs-Stage4
9.428800E-01
Stage3-vs-Stage4
1.210790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.030600E-01
Normal-vs-AfricanAmerican
7.123600E-01
Normal-vs-Asian
2.277000E-01
Caucasian-vs-AfricanAmerican
5.885200E-01
Caucasian-vs-Asian
3.230200E-01
AfricanAmerican-vs-Asian
3.378400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.296000E-01
Normal-vs-Female
4.485200E-01
Male-vs-Female
7.216200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.003210E-01
Normal-vs-Age(41-60Yrs)
7.002200E-01
Normal-vs-Age(61-80Yrs)
3.243200E-01
Normal-vs-Age(81-100Yrs)
6.403800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.564200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.927600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.394600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.254400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.274600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.913000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.294400E-01
Normal-vs-Daily Drinker
2.892000E-01
Normal-vs-Weekly Drinker
4.097800E-01
Normal-vs-Occasional Drinker
9.160200E-01
Normal-vs-Social Drinker
6.593000E-01
Non Drinker-vs-Daily Drinker
8.594400E-01
Non Drinker-vs-Weekly Drinker
8.125600E-01
Non Drinker-vs-Occasional Drinker
4.775900E-02
Non Drinker-vs-Social Drinker
2.970200E-01
Daily Drinker-vs-Weekly Drinker
7.088400E-01
Daily Drinker-vs-Occasional Drinker
4.696300E-02
Daily Drinker-vs-Social Drinker
2.504800E-01
Weekly Drinker-vs-Occasional Drinker
1.541380E-01
Weekly Drinker-vs-Social Drinker
4.908600E-01
Occasional Drinker-vs-Social Drinker
3.951600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.164000E-01
Normal-vs-Grade 2
4.146000E-02
Normal-vs-Grade 3
8.133600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.575600E-02
Grade 1-vs-Grade 3
9.841400E-03
Grade 1-vs-Grade 4
2.164000E-01
Grade 2-vs-Grade 3
1.051030E-01
Grade 2-vs-Grade 4
4.146000E-02
Grade 3-vs-Grade 4
8.133600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.107400E-01
Normal-vs-NonDiabetic
4.569200E-01
Diabetic-vs-NonDiabetic
3.624200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.775600E-02
Normal-vs-NoPancreatitis
4.266400E-01
Pancreatitis-vs-NoPancreatitis
1.530020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.942400E-01
Normal-vs-N1
5.219600E-01
N0-vs-N1
1.341250E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.797800E-01
Normal-vs-TP53-NonMutant
1.490990E-01
TP53-Mutant-vs-TP53-NonMutant
9.95400000000091E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
